See more : alstria office REIT-AG (AOX.SW) Income Statement Analysis – Financial Results
Complete financial analysis of TriplePoint Venture Growth BDC Corp. (TPVG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of TriplePoint Venture Growth BDC Corp., a leading company in the Asset Management industry within the Financial Services sector.
- KUKA Aktiengesellschaft (KUKAY) Income Statement Analysis – Financial Results
- Cincinnati Financial Corporation (0HYE.L) Income Statement Analysis – Financial Results
- India Nippon Electricals Limited (INDNIPPON.BO) Income Statement Analysis – Financial Results
- Chico’s FAS, Inc. (CHS) Income Statement Analysis – Financial Results
- Taneja Aerospace and Aviation Limited (TANAA.BO) Income Statement Analysis – Financial Results
TriplePoint Venture Growth BDC Corp. (TPVG)
About TriplePoint Venture Growth BDC Corp.
TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 61.73M | 119.42M | 83.37M | 42.00M | 40.20M | 41.53M | 24.64M | 15.59M | 22.54M | 29.94M |
Cost of Revenue | -75.76M | 24.66M | 24.79M | 23.26M | 18.47M | 15.62M | 13.29M | 9.85M | 11.01M | 0.00 |
Gross Profit | 137.49M | 94.76M | 58.58M | 18.74M | 21.73M | 25.91M | 11.35M | 5.74M | 11.53M | 29.94M |
Gross Profit Ratio | 222.74% | 79.35% | 70.26% | 44.62% | 54.05% | 62.40% | 46.08% | 36.81% | 51.15% | 100.00% |
Research & Development | 0.00 | -0.27 | 1.14 | 0.35 | 0.44 | 0.55 | 0.37 | 0.49 | 0.00 | 0.00 |
General & Administrative | 9.00M | 6.70M | 6.13M | 6.70M | 6.04M | 4.96M | 4.30M | 4.47M | 4.35M | 10.37M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 9.00M | 6.70M | 6.13M | 6.70M | 6.04M | 4.96M | 4.30M | 4.47M | 4.35M | 10.37M |
Other Expenses | -36.07M | 51.42M | 681.00K | 38.76M | 2.40M | 2.55M | 3.63M | 2.58M | 2.67M | 0.00 |
Operating Expenses | -27.07M | 6.70M | 6.81M | 6.70M | 8.44M | 4.96M | 5.41M | 4.47M | 7.02M | 8.12M |
Cost & Expenses | -27.07M | 55.87M | 6.81M | 6.70M | 8.44M | 18.54M | 16.18M | 12.77M | 14.14M | 8.12M |
Interest Income | 133.25M | 116.57M | 82.83M | 88.57M | 70.52M | 62.61M | 50.04M | 41.77M | 39.90M | 4.68M |
Interest Expense | 33.04M | 26.76M | 17.37M | 15.49M | 10.01M | 9.08M | 9.06M | 7.86M | 3.62M | 0.00 |
Depreciation & Amortization | 0.00 | 66.73M | -27.22M | 48.93M | 28.60M | 29.75M | 31.01M | 11.79M | -2.82M | -20.05M |
EBITDA | 0.00 | 0.00 | 0.00 | -12.55M | -6.50M | 45.64M | 28.29M | 18.99M | 19.14M | -5.76M |
EBITDA Ratio | 0.00% | 68.61% | 91.83% | 84.06% | 79.00% | 103.78% | 104.60% | 105.25% | 84.92% | -9.67% |
Operating Income | 73.81M | 90.32M | 76.56M | 35.31M | 31.76M | 34.99M | 26.27M | 23.01M | 21.96M | 20.05M |
Operating Income Ratio | 119.57% | 75.63% | 91.83% | 84.06% | 79.00% | 84.26% | 106.60% | 147.59% | 97.43% | 66.95% |
Total Other Income/Expenses | -113.63M | -62.13M | -3.06M | 23.26M | -14.09M | 1.57M | -7.04M | -11.89M | 0.00 | -5.28M |
Income Before Tax | -39.82M | -20.07M | 76.56M | 35.31M | 31.76M | 36.56M | 19.23M | 11.13M | 15.52M | 17.15M |
Income Before Tax Ratio | -64.51% | -16.81% | 91.83% | 84.06% | 79.00% | 88.05% | 78.03% | 71.36% | 68.87% | 57.28% |
Income Tax Expense | 0.00 | 26.76M | 40.42M | 47.85M | 38.25M | 7.95M | 29.40M | 18.99M | 296.00K | -2.90M |
Net Income | -39.82M | -46.83M | 76.56M | 35.31M | 31.76M | 36.56M | 19.23M | 11.13M | 15.52M | 17.15M |
Net Income Ratio | -64.51% | -39.21% | 91.83% | 84.06% | 79.00% | 88.05% | 78.03% | 71.36% | 68.87% | 57.28% |
EPS | -1.12 | -1.43 | 2.47 | 1.16 | 1.28 | 1.78 | 1.18 | 0.69 | 1.03 | 1.74 |
EPS Diluted | -1.12 | -1.43 | 2.47 | 1.16 | 1.28 | 1.78 | 1.18 | 0.69 | 1.03 | 1.74 |
Weighted Avg Shares Out | 35.71M | 32.69M | 30.94M | 30.57M | 24.84M | 20.49M | 16.32M | 16.16M | 15.04M | 9.87M |
Weighted Avg Shares Out (Dil) | 35.71M | 32.69M | 30.94M | 30.57M | 24.84M | 20.49M | 16.32M | 16.16M | 15.04M | 9.87M |
BDC Weekly Review: Key Q3 Earnings Trends
Hold This 15% Yield For Big Income: TriplePoint Venture
Investing In BDCs For 10%+ Yields? This Is What Matters Now
BDC Weekly Review: Tax-Loss Season Is Approaching
TriplePoint Venture Growth: Inflection Point (Rating Upgrade)
TriplePoint Venture Growth: The Worst May Be Over (Rating Upgrade)
TriplePoint Venture Growth (TPVG) Q3 2024 Earnings Call Transcript
TriplePoint Venture Growth (TPVG) Beats Q3 Earnings and Revenue Estimates
TriplePoint Venture Growth BDC Corp. Announces Third Quarter 2024 Financial Results
Readers Identify 25 Ideal September Dividend Buys Out Of 39 Picks
Source: https://incomestatements.info
Category: Stock Reports